Company intelligence / Profile preview
Wasserman Medic
- Ownership
- Private
- Development stage
- Other
Overview
Wasserman Medic is an Italian pharmaceutical company with a long-standing history in the development and commercialization of therapeutic products. The company focuses on several key therapeutic areas, including gastroenterology, respiratory health, and pain management, offering a range of established branded generic and specialty medicines. In recent years, Wasserman Medic was acquired by the Spanish pharmaceutical group Almirall, which integrated Wasserman's portfolio to strengthen its presence in the Italian market. Today, the company operates as a subsidiary, continuing to provide essential healthcare solutions and maintaining a significant commercial footprint in Italy.
- Therapeutic areas
- CardiovascularPulmonologyNeurologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Wasserman Medic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wasserman Medic.